Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Effect of a New Anticancer Agent, 1,4-Dimethyl-1,4-Diphenyl-2-Tetrazene, on a Transplantable Mammary Adenocarcinoma (72j) and Spontaneous Mouse Breast Tumours

Nature volume 197, pages 85–86 (1963)Cite this article

Abstract

1,4-DIMETHYL-1,4-DIPHENYIL-2-TETRAZENE1 (MPT) inhibits the growth of transplanted 72j mammary adenocarcinoma carried in C3H mice. Its activity was found during the screening2,3 of compounds structurally related to the antineoplastic agent 3,3-dimethyl-1-phenyltriazene4. The corresponding 1,4-diethyl5 and 1,4-di(p-nitrophenyl) analogues of MPT were also found active against this tumour. Extensive laboratory evaluation of MPT and synthesis of additional compounds are in progress and will be reported in detail6,7. The following biological findings were considered to be of immediate interest.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Fischer, E., Ann. Chem., 190, 166 (1878).

    Article  Google Scholar 

  2. Dearborn, E. H., Acta Unio. Contra Cancrum, 15, Supp. 1, 76 (1959).

    CAS  Google Scholar 

  3. Vogel, A. W., and Haynes, J. H., Cancer Chemother. Rep., 22, 23 (1962).

    CAS  PubMed  Google Scholar 

  4. Clarke, D. A., Barclay, R. K., Stock, C. C., and Rondestvedt, jun., C. S., Proc. Soc. Exp. Biol. Med., 90, 484 (1955).

    Article  CAS  Google Scholar 

  5. Fischer, E., and Ehrhardt, W., Ann. Chem., 199, 326 (1879).

    Google Scholar 

  6. Sloboda, A., and Vogel, A. W. (in preparation).

  7. Tomcufcik, A. S., and Child, R. G. (in preparation).

  8. Goldin, A., J. Nat. Cancer Inst., 17, 203 (1956).

    CAS  PubMed  Google Scholar 

  9. Vogel, A. W., Cancer Res., 21, 1450 (1961).

    CAS  PubMed  Google Scholar 

  10. Friedman, D. M., and Boger, E., Anal. Chem., 33, 906 (1961).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Metabolic Chemotherapy and Chemotherapy, Lederle Laboratories, American Cyanamid Co., Pearl River, New York

    ADOLPH W. VOGEL, ADOLPH E. SLOBODA, ANDREW S. TOMCUFCIK & RALPH G. CHILD

Authors
  1. ADOLPH W. VOGEL
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. ADOLPH E. SLOBODA
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. ANDREW S. TOMCUFCIK
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. RALPH G. CHILD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

VOGEL, A., SLOBODA, A., TOMCUFCIK, A. et al. Effect of a New Anticancer Agent, 1,4-Dimethyl-1,4-Diphenyl-2-Tetrazene, on a Transplantable Mammary Adenocarcinoma (72j) and Spontaneous Mouse Breast Tumours. Nature 197, 85–86 (1963). https://doi.org/10.1038/197085b0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/197085b0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing